We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-14.79%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$4.14B
AUM Growth
-$73.7M
Cap. Flow
+$1.39B
Cap. Flow %
33.49%
Top 10 Hldgs %
76.41%
Holding
58
New
15
Increased
–
Reduced
10
Closed
–

Top Buys

Rank Stock Value
1
EQRX
EQRx, Inc. Common Stock
EQRX
+$449M
2
TOST icon
Toast
TOST
+$439M
3
IONQ icon
IonQ
IONQ
+$365M
4
PL icon
Planet Labs
PL
+$303M
5
FRSH icon
Freshworks
FRSH
+$146M

Top Sells

Rank Stock Value
1
PATH icon
UiPath
PATH
+$173M
2
HOOD icon
Robinhood
HOOD
+$85.2M
3
DUOL icon
Duolingo
DUOL
+$78.2M
4
RCUS icon
Arcus Biosciences
RCUS
+$59.6M
5
DXCM icon
DexCom
DXCM
+$58.4M

Sector Composition

Rank Sector Weight
1 Healthcare 47.14%
2 Technology 41.19%
3 Industrials 6.55%
4 Consumer Staples 2.6%
5 Financials 2.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRON
26
DELISTED
Kronos Bio
KRON
$19.5M 0.47%
1,438,232
– –
VERA icon
27
Vera Therapeutics
VERA
$2.53B
$19.1M 0.46%
713,658
-231,133
-24% -$5.11M
BRNS
28
Barinthus Biotherapeutics
BRNS
$24.6M
$18.9M 0.46%
1,704,344
-100
-0% -$1.26K
IDYA icon
29
IDEAYA Biosciences
IDYA
$3.54B
$17.8M 0.43%
753,187
– –
TNYA icon
30
Tenaya Therapeutics
TNYA
$167M
$17.4M 0.42%
915,705
– –
DUOL icon
31
Duolingo
DUOL
$6.19B
$15.3M 0.37%
144,444
-567,860
-80% -$78.2M
DNTH icon
32
Dianthus Therapeutics
DNTH
$5.71B
$14.8M 0.36%
208,696
– –
SPRO icon
33
Spero Therapeutics
SPRO
$68.3M
$14.2M 0.34%
889,979
– –
FHTX icon
34
Foghorn Therapeutics
FHTX
$305M
$11.5M 0.28%
500,901
– –
AMPL icon
35
Amplitude
AMPL
$1.15B
$10M 0.24%
189,447
– –
NEWR
36
DELISTED
New Relic, Inc.
NEWR
$10M 0.24%
91,132
– –
DBTX
37
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$7.61M 0.18%
1,636,258
– –
TSHA icon
38
Taysha Gene Therapies
TSHA
$1.59B
$7.47M 0.18%
640,882
– –
S icon
39
SentinelOne
S
$6.22B
$6.99M 0.17%
+138,503
New +$8.12M
OMIC
40
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$6.78M 0.16%
19,553
-2,001
-9% -$776K
HYPR icon
41
Hyperfine
HYPR
$95.3M
$6.52M 0.16%
+898,720
New +$7.12M
EVLO
42
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$6.44M 0.16%
53,025
– –
TCRX icon
43
TScan Therapeutics
TCRX
$50.2M
$4.85M 0.12%
1,077,080
– –
FULC icon
44
Fulcrum Therapeutics
FULC
$249M
$4.52M 0.11%
255,452
– –
ALEC icon
45
Alector
ALEC
$168M
$3.63M 0.09%
175,866
– –
AUTL
46
Autolus Therapeutics
AUTL
$389M
$3.62M 0.09%
698,262
– –
NVTA
47
DELISTED
Invitae Corporation
NVTA
$3.3M 0.08%
215,965
– –
QNCX icon
48
Quince Therapeutics
QNCX
$17.5M
$2.39M 0.06%
946
– –
UBER icon
49
Uber
UBER
$139B
$2.07M 0.05%
49,466
– –
OPRT icon
50
Oportun Financial
OPRT
$262M
$1.92M 0.05%
+94,788
New +$2.22M
1
2
3

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q4 2021 Portfolio in Review

As of Q4 2021, Alphabet Inc held 58 positions worth $4.14B, down 1.7% from $4.22B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Alphabet Inc deployed $1.39B of net new capital in Q4 2021, opening 15 new positions. Its largest new stake was EQRx, Inc. Common Stock: 47,552,687 shares worth $324M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 55% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was UiPath, an estimated $173M trimmed.

  • Alphabet Inc's largest Q4 2021 buy was EQRx, Inc. Common Stock: 47,552,687 shares worth $324M.
  • Alphabet Inc's biggest Q4 2021 reduction was UiPath, cutting an estimated $173M.
  • Alphabet Inc's ten largest holdings make up 76% of its $4.14B portfolio in Q4 2021.
  • Alphabet Inc opened 15 new positions and closed 0 in Q4 2021.
  • Alphabet Inc's portfolio value fell 1.7% quarter-over-quarter to $4.14B.

Based on Alphabet Inc's 13F filing for Q4 2021, filed 15 Nov 2022.